Sun-Ranbaxy merger: AP High Court verdict on Saturday

Our Bureau Updated - March 12, 2018 at 09:15 PM.

The Andhra Pradesh High Court on Friday reserved judgement on a plea requesting the court to direct SEBI to investigate into insider trading related to merger of Ranbaxy with Sun Pharmaceuticals. The order would be issued tomorrow, the court said.

The petition was filed by two investors.

While denying the charge of insider trading, Counsel for Ranbaxy argued that there was no link between insider trading and merger deal and market regulator had already initiated the probe into it.

SEBI counsel submitted to the court that investigation into insider trading charges was on.

Published on May 23, 2014 12:25